Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Pharmacyclics Inc (PCYC)    
$137.07 0.00 (0.00%) as of 4:30 Tue 11/18


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 73,583,000 as of 6/30
Market Cap: 10.09(B)
Last Volume: 374,105 Avg Vol: 842,158
52 Week Range: $85.85 - $151.61
Level I Sector: Health Care
Level II Sector:   Drugs
Level III Sector:      Drug Manufacturers - Other

Member Indexes:

    NASDAQ BIOTECHNOLOGY       NASDAQ COMPOSITE  
    NASDAQ NNM COMPOSITE  

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
 

Company Profile   Pharmacyclics is a biopharmaceutical company focused on developing and commercializing small-molecule drugs for the treatment of cancer and immune mediated diseases. Co. has three proprietary drug candidates under clinical development and several preclinical lead molecules: an inhibitor of Bruton's tyrosine kinase (BTK) ibrutinib in several Phase III studies in hematologic malignancies, a BTK inhibitor lead optimization program targeting anti-inflammatory and autoimmune indications, an inhibitor of Factor VIIa in a Phase II clinical trial in pancreatic cancer and a histone deacetylase inhibitor, abexinostat, in Phase I and II clinical trials in solid tumors and hematological malignancies.

 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 52,982 102,544 345,914 750,950
Total Sell Value $7,005,273 $13,029,731 $44,172,261 $71,628,379
Total People Sold 4 6 12 15
Total Sell Transactions 9 13 29 52
End Date 2014-08-28 2014-05-27 2013-11-26 2012-11-26

   
Records found: 373
  Page 1 of 15  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Tomasello Shawn Chief Commercial Officer   •       –      –    2014-11-19 4 D $138.37 $745,801 D/D (5,390) 57,110     -
   Soni Manmeet Singh Chief Financial Officer   •       –      –    2014-11-13 4 S $141.44 $141,442 D/D (1,000) 38,611 -1%     
   Soni Manmeet Singh Chief Financial Officer   •       –      –    2014-11-13 4 OE $61.60 $61,600 D/D 1,000 39,611     -
   Fardis Maria Chief of Oncology Ops & Allian   •       –      –    2014-11-13 4 S $141.30 $423,902 D/D (3,000) 3,193 -1%     
   Fardis Maria Chief of Oncology Ops & Allian   •       –      –    2014-11-13 4 OE $6.84 $20,520 D/D 3,000 6,193     -
   Zanganeh Maky Chief Operating Officer   •       –      –    2014-11-12 4 OE $7.19 $42,644 D/D 5,931 216,243     -
   Zanganeh Maky Chief Operating Officer   •       –      –    2014-11-12 4 S $137.50 $818,216 D/D (5,931) 210,312 -1%     
   Love Richard B General Counsel   •       –      –    2014-11-10 4 OE $32.38 $48,570 D/D 1,500 1,705     -
   Zanganeh Maky Chief Operating Officer   •       –      –    2014-11-10 4 OE $2.30 $52,900 D/D 23,000 233,312     -
   Love Richard B General Counsel   •       –      –    2014-11-10 4 S $133.87 $200,805 D/D (1,500) 205 -4%     
   Zanganeh Maky Chief Operating Officer   •       –      –    2014-11-10 4 S $133.50 $3,078,027 D/D (23,000) 210,312 -4%     
   Zanganeh Maky Chief Operating Officer   •       –      –    2014-11-07 4 S $135.01 $209,401 D/D (1,551) 210,312 -2%     
   Zanganeh Maky Chief Operating Officer   •       –      –    2014-11-07 4 OE $2.30 $3,567 D/D 1,551 211,863     -
   Fardis Maria Chief of Oncology Ops & Allian   •       –      –    2014-11-07 4 S $134.50 $672,500 D/D (5,000) 3,193 -2%     
   Fardis Maria Chief of Oncology Ops & Allian   •       –      –    2014-11-07 4 OE $6.84 $34,200 D/D 5,000 8,193     -
   Soni Manmeet Singh Chief Financial Officer   •       –      –    2014-10-31 4 A $80.93 $81 D/D 1 38,611     -
   Love Richard B General Counsel   •       –      –    2014-10-31 4 A $80.93 $81 D/D 1 205     -
   Zanganeh Maky Chief Operating Officer   •       –      –    2014-10-31 4 A $80.93 $81 D/D 1 210,312     -
   Fardis Maria Chief of Oncology Ops & Allian   •       –      –    2014-10-31 4 A $80.93 $81 D/D 1 3,193     -
   Tan Heow Chief Quality&Tech Operations   •       –      –    2014-10-31 4 A $80.93 $81 D/D 1 4,070     -
   Zanganeh Maky Chief Operating Officer   •       –      –    2014-09-04 4 S $122.00 $610,000 D/D (5,000) 210,311 -13%     
   Zanganeh Maky Chief Operating Officer   •       –      –    2014-09-04 4 OE $2.30 $11,500 D/D 5,000 215,311     -
   Zanganeh Maky Chief Operating Officer   •       –      –    2014-09-03 4 S $121.10 $850,980 D/D (7,000) 210,311 -13%     
   Zanganeh Maky Chief Operating Officer   •       –      –    2014-09-03 4 OE $2.30 $16,100 D/D 7,000 217,311     -
   Love Richard B General Counsel   •       –      –    2014-08-27 4 OE $32.38 $48,570 D/D 1,500 1,704     -

  373 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 15
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed